Loading...
HomeMy WebLinkAbout1994/08/23 Item 8 COUNCIL AGENDA STATEMENT SUBMITTED BY: Item g Meeting Date 8/23/94 Resolution / 7 J,...2:J Accepting the Feasibility Study regarding a shared biotechnical pilot manufacturing facility; authorizing payment to Nielsen Capital Group, Inc.; and authorizing the Mayor and Mayor-Elect to sign a Letter of Support for BioShare (\l Director of Community Development f:JI' City Manage~ ~~ (4/5ths Vote: Yes_No_KJ ITEM TITLE: REVIEWED BY: BACKGROUND: On February 4, 1994 Council approved an agreement with Nielsen Capital Group, Inc. for the preparation of a feasibility study regarding a contract biotech pilot manufacturing facility within the new High TechlBiotech Zone at the Eastlake Business Center. The study was intended to analyze the High TechlBiotech Task Force's recommendation that the City act as a catalyst to the development of this type of operation/facility in order to "seed" the Zone for tenant companies as well as "spin-off" full manufacturing plants. The Study was approved in the amount of $18,500, with 50% to be paid up front by Eastlake and the other 50% to be paid upon acceptance by the City. RECOMMENDATION: That the Council accept the Feasibility Study regarding a contract biotech pilot manufacturing facility; authorize final payment of $9,250 to Nielsen Capital Group, Inc.; and authorize the Mayor and Mayor-Elect to sign the attached Letter of Support for BioShare (Attachment A). BOARDS/COMMISSIONS RECOMMENDATION: Not applicable. DISCUSSION: Need for a Contract Pilot Manufacturing Facilitv/Business The San Diego area currently is home to numerous biotech pharmaceutical R&D firms. Only 2-3 have moved into pilot manufacturing at this time. However, it is anticipated that many R&D firms will be moving into pilot manufacturing and ultimately full manufacturing in the next 3-10 years. A contract pilot manufacturing facility could potentially meet the needs of biotech pharmaceuticals going into Phase I and Phase II clinical trials (pilot manufacturing). Current options are limited to the development by individual companies of dedicated (stand-alone) pilot manufacturing plants, which is extremelv costly, or "outsourcing", i.e. leasing pilot manufacturing space from traditional pharmaceutical companies (who typically take a chunk of the ownership) or from foreign "contract" facilities This preliminary study was done to determine the feasibility of developing a facility at Eastlake that could be leased out ("contracted") to save companies moving from R&D to pilot manufacturing from having to go into real estate development, just to have to leave the pilot plant after a year or so and build another full, scaled-up manufacturing facility. The Feasibility Study was to evaluate market demand, the proposed scope of ~'J Page 2, Item1 Meeting Date 8/23/94 operations and services, alternative forms of organization and governance, and roles for the City and for Eastlake, and to make preliminary recommendations regarding how the City should proceed. Studv Findings The study concludes that a two-suite "process development and bacterial fermentation" contract production facility (with expansion potential) is conceptually feasible. All biotechnology companies must conduct clinical trials before bringing products to market. Highly regulated and specialized facilities are needed for such production; however, at the present time such resources have to be purpose-built, typically at great expense. Critics argue that such large cash outlays are directly associated with the volatility experienced in the biotechnology capital markets. Currently, the domestic biotechnology industry consists of more than 1200 compames who have approximately 270 products in various stages of clinical trials. This supports the premise that the biotechnology industry is just now maturing to a point where demand to support a contract manufacturing facility will be sufficient. The West Coast is an ideal location for such a facility due to the fact that California is home to about one-half of the nation's biotechnology companies. The Chula Vista location would allow access and coordination to occur between the client companies' operations and the contract facility. Excellent transportation by air and overland as well as the facility being in the same time zone as facilities currently in operation in California, Oregon and Washington will be important to the productivity of such a coordination effort. Several key factors to the successful implementation ofthis project include, but are not limited to: a good business plan, an uninterruptable supply of water, special-purpose centralized utilities, timely entitlements, an experienced management team, attraction of financing, being first to market, expertise in essential technical areas, and necessary features of the physical plant itself. The study finds that a BioShare-like facility is "fundamental to the establishment of biotech manufacturing businesses in the High TechlBiotech Zone", and that "the window of opportunity exists now and may close should a competing facility be announced elsewhere in the Western United States." Formation of BioShare CoroorationlLetter of Support Nielsen Capital Group, Inc., its sub-consultants, Mr. John Tedesco of Amylin Pharmaceuticals and Mr. Aron Stern of Protein Polymer Technologies, and others, including Nielsen Construction Company and its affiliates, are in the process of forming a California corporation called "BioShare" to establish and fund the proposed contract manufacturing business in the City's High TechIBiotech Zone. They have requested that the City approve the attached Letter of Support indicating the City's intent to cooperate with "Bioshare" in order to achieve certain goals (see Attachment A). The stated goals are consistent with the City's High TechlBiotech Zone program, and by supporting this proposal, the City is recognizing not only the talent and expertise brought to the BioShare project, but also the keen time sensitivity of the proposal. 11'.;... Page 3, Item Meeting Date 8/23/94 y The City Attorney has reviewed the letter and finds it to be acceptable. He has also drafted a related letter to Mr. Carlin clarifying the fact that the City is not committing to any specific obligations at this time or to compensate BioShare for any future work (see Attachment B). FISCAL IMPACT: The Feasibility Study contract is for a total of$18,500. Eastlake has paid the initial 50% or $9,250. Council is requested to authorize the $9,250 balance to be paid from the previously encumbered FY 1993/94 Economic Development budget (Account 100-261-5201). Approval of the Letter of Support will require significant staff time to assist with the items delineated, but no direct cost will be incurred by the City. In the event that any of the items referenced are determined to have a direct fiscal impact to the City, each such item would be brought forward to Council for advance approval. ATTACHMENTS (2) . ~~\) Attachment A - Letter of Support datcd 8/9/94 <CO ~~..... . Attachment B - City Attorney letter dated Si{(6 ). [(CD/md) c:\wpSI\document\bioshre.113] 3"..J RESOLUTION J '7 t ~3 RESOLUTION OF THE CITY COUNCIL OF THE CITY OF CHULA VISTA ACCEPTING THE FEASIBILITY STUDY REGARDING A SHARED BIOTECHNICAL PILOT MANUFACTURING FACILITY, AUTHORIZING PAYMENT TO NIELSEN CAPITAL GROUP, INC., AND AUTHORIZING THE MAYOR AND MAYOR-ELECT TO SIGN A LETTER OF SUPPORT FOR BIOSHARE WHEREAS, on February 4, 1994 the City Council approved an agreement with Nielsen Capital Group, Inc., for the preparation of a Feasibility Study regarding a contract biotech pilot manufacturing facility within the new High Tech/Biotech Zone at the EastLake Business Center; and WHEREAS, the Study analyzed the High Tech/BioTech Task Force's recommendation that the City act as a catalyst to the development of this type of operation/facility in order to "seed" the Zone for tenant companies as well as "spin-off" full manufacturing plans; and WHEREAS, Nielsen Capital Group, Inc. has completed the Feasibility Study which concluded that a two-suite "process development and bacterial fermentation" contract production facility (with expansion potential) is conceptually feasible; and WHEREAS, Nielsen Construction Company and its affiliates are in the process of forming a California corporation called "BioShare" to establish and fund the proposed contract manufacturing business in the City of Chula Vista's High Tech/BioTech Zone and have requested a Letter of Support indicating the City's intent to cooperate in order to achieve certain goals which are consistent with the High Tech/BioTech Zone Program; and WHEREAS, the City Attorney has reviewed the Letter and finds it to be acceptable and has prepared a letter to Nielsen Capital Group, Inc., clarifying the fact the City is not committing to any specific obligations at this time or to compensate BioShare for any future work. NOW THEREFORE, THE CITY COUNCIL OF THE CITY OF CHULA VISTA does hereby find, order, determine and resolve: 1. That the City Council accepts the Feasibility Study regarding a shared biotechnical pilot manufacturing facility prepared by Nielsen Capital Group, Inc. 2. That the City Council hereby authorizes payment to Nielsen Capital Group, Inc., for its portion of the Feasibility Study. 3. That the City Council hereby authorizes the Mayor and Mayor-Elect to sign the Letter of Support for BioShare as submitted to Council for approval. ~~ Ai 0 ED AS Tf FO / vk (Bruce M. Boogaard City Attorney BY: PRESENTED BY: ~ Chris Salomone Community Development Director [C:IWP51 ICOUNCILIRESDSIBIDSHA RE.RESI rr"i ~\ft- ~j: ~~=t-~' ATTACHMENT "A" OFFICE OF THE MAYOR TIM NADER ON OF -CHULA VISTA August 9, 1994 Mr. Bruce Carlin BioShare clo Nielsen Capital Group, Inc. P.O. Box 83848 San Diego, CA 92138-3848 Reference: The City of Chula Vista's Support for BioShare Dear Mr. Carlin: In April of this year, the City of Chula Vista retained your services, as the principal of Nielsen Capital Group, Inc., to advise the City regarding the feasibility of a shared or contract manufacturing facility for the biotechnology industry. This facility would be located in the City's High Tech/Biotech Zone. Your Feasibility Study report has been received and accepted by the City, and we understand from your research that the proposed BioShare business appears to be feasible. Furthermore, you have indicated that you and your sub-consultants and others, including Nielsen Construction Company and its affiliates, are in the process of forming a California corporation called BioShare to establish and fund the proposed contract manufacturing business in the City's High Tech/Biotech Zone. We are pleased to inform you that the City Council has directed the undersigned to inform you, the other co-founders of BioShare and your potential investors, clients and tenants that the City is in full support of your efforts. In particular, pending our review of your business plan, the City intends to cooperate with BioShare's efforts in order to achieve the following goals: · To arrange for an uninterrupted supply of water to the contract manufacturing facility and proximate dedicated biotech manufacturing facilities ("the Project") at reasonable utility rates. · To help arrange for specialized sewage treatroent and water reclamation facilities for the Project. · To arrange for the donation of approximately 6 acres of properly zoned and fully- entitled land, by Eastlake Development Company, to BioShare for its use in establishing the contract manufacturing business. · To secure reservations from biotechnology company clients and sponsors for the BioShare facility and services. r.5 276 FOURTH AVENUE/CHULA VISTA. CALIFORNIA 919101(619) 691-5044 \ BioShare August 9, 1994 Page 2 · To gain financial and other support for BioShare from investors and State and Federal government officials. · To establish terms for an exclusive Agreement between BioShare and the City, whereby the City would exclusively support, and not compete with, BioShare's efforts to establish the BioShare contract manufacturing business within the City's High Tech/Biotech Zone at the Eastlake Business Center, and BioShare would agree to develop the project in accordance with City approved plans. The City of Chula Vista looks forward to working closely with you and your associates to establish tl1is remarkable business opportunity in our community. Sincerely, Tim Nader Mayor Shirley Horton Mayor-Elect TN:SHfCDfmd [(MD)c:\wp51\document\38.94(rev. August 10, 1994)1 ~,~ CITY OF CHULA VISTA ~V~ ~ -:....~- - ATTACHMENT "B" ON OF CHUlA VISTA COMMUNITY DEVELOPMENT DEPARTMENT August 17, 1994 Mr. Bruce Carlin Nielsen Capital Group, Inc. P.O. Box 83848 San Diego, CA 92138-3848 Dear Mr. Carlin: On August 9, 1994, Mayor Nader and Mayor-Elect Horton wrote to you to express the City's continuing strong support of your efforts to develop a BioShare contract biotech pilot manufacturing facility/business. As you know, however, many of the significant terms of the City's ongoing relationship with BioShare remain undetermined. Accordingly, the purpose of this letter is to clarify the extent of the City's legal commitment to BioShare at this time with respect to the development of the BioShare project. While the City fully intends to cooperate with BioShare to work towards the goals outlined in the August 9, 1994 letter, the City at this point in time has undertaken no specific duties or obligations to BioShare to compensate BioShare for any continuing work in its development of the project or to otherwise work towards the achievement of such goals other than the good faith obligation to 1) take all reasonable measures mutually agreed upon by the City and BioShare to achieve such goals; and 2) to meet and confer with BioShare and Eastlake on an ongoing basis in order to attempt to finalize the terms of the formal agreements necessary to fully implement the BioShare project. Such agreements will include, among others, the terms for providing uninterrupted water to the facility, the terms for the provision of specialized sewage treatment and water reclamation facilities, the terms for the donation of 6 acres of land to the project and the terms upon which the City would enter into an exclusive arrangement with BioShare for the development of the project. The City retains its sole and unfettered discretion in determining whether or not to approve any or all of such agreements. Based upon the above understanding, the August 9 letter should not be submitted to any prospective tenants, lenders or investors as evidence of the City's final commitment on any of these matters. In the event that the letter is so submitted, BioShare and its principals shall be obligated to indemnify and hold the City harmless from and against any and all third party claims against the City arising from such submittal. If the terms of this letter are agreeable to you please execute the enclosed copy, where indicated, and return to my attention. Sincerely, Bruce M. Boogaard City Attorney Approved and Agreed: Bruce Carlin IMDIC:IWP51IDDCUMENTI39.941 Y~7 276 FOURTH AVE/CHULA VISTA. CALIFORNIA 91910/(619) 691 5047